BUZZ-DexCom shares rise after raising the lower end of its 2026 revenue forecast range

October 29 - ** DexCom (DXCM.O) shares rose 2.6% in after-hours trading to $81.97

** The medical device maker expects (link) 2026 revenue to range between $5.20 billion and $5.25 billion, up from the previous forecast range of $5.18 billion to $5.25 billion

** The company reported third-quarter revenue of $1.34 billion, beating analysts’ consensus estimate of $1.327 billion — according to LSEG data

** The company also announced approval of a stock buyback program of up to $1 billion

** As of the previous session’s close, the stock has gained 20.4% year to date

(To facilitate non-native English speakers, Reuters offers automated translations of its reports into several other languages. As automated translations may contain errors or lack necessary context, Reuters does not guarantee the accuracy of the translated text and provides it solely for reader convenience. Reuters accepts no responsibility for any damage or loss caused by the use of the automated translation tool.)